PMID: 2439187Aug 1, 1987Paper

Biologic response modifiers in genitourinary neoplasia

Cancer
M J Droller

Abstract

With the exception of testis cancer, the variety of genitourinary cancers have not been found to be consistently responsive to chemotherapeutic agents or regimens for other than anecdotal short duration. This has generated keen interest in the possibility that biologic response modifiers might either directly or through manipulation of immune response mechanisms successfully prevent tumor progression in these systems. In recent years, those substances that have attracted the greatest attention have included interferon (and, more recently, recombinant gamma interferon), bacillus Calmette-Guerin (BCG), tumor necrosis factor, prostaglandin synthetase inhibitors, and interleukin-2. Results with each of these agents in the variety of genitourinary cancers have been both promising and disappointing. A number of mechanisms have been suggested to underlie the actions of each of these substances, and the successful or unsuccessful recruitment of these mechanisms, in the context of the particular intrinsic behavior of the cancers being treated, have been suggested as reasons for the treatment results that have been seen. Therapeutic efficacy has been described in the treatment of renal cell cancer by both systemic interferon and interleu...Continue Reading

References

Jan 1, 1977·Advances in Cancer Research·S A Rosenberg, W D Terry
Jan 1, 1978·Advances in Cancer Research·H B Hewitt
Jan 1, 1979·Pharmacology & Therapeutics·M S Mitchell, R I Murahata
Jan 1, 1976·Annals of the New York Academy of Sciences·M J MastrangeloR E Bellet
Aug 12, 1977·Science·R M SchultzM A Chirigos
Oct 1, 1977·Annals of Surgery·K P Ramming, J B deKernion
Jan 1, 1976·Annals of the New York Academy of Sciences·Y H PilchD H Kern
Sep 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·E A CarswellB Williamson
Apr 1, 1976·Annals of Internal Medicine·J L FaheyJ Zighelboim
May 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L FinstadL J Old
Aug 25, 1973·Lancet·P GuinanR J Ablin
Jun 20, 1974·The New England Journal of Medicine·R C BastH J Rapp
Oct 1, 1974·Cancer·C F McKhann, A Gunnarsson
Feb 29, 1968·The New England Journal of Medicine·R E WilsonJ E Murray
Jan 1, 1966·Annual Review of Microbiology·G Klein
Jan 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·Y FradetL J Old
Sep 1, 1983·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R K Oldham
Dec 1, 1983·The Journal of Urology·J B deKernionR B Smith
Jan 15, 1982·Science·J L Marx
Apr 1, 1982·Current Problems in Cancer·I Penn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.